Constipation is a motility problem, not a bulk problem

Most constipation remedies add bulk (fiber laxatives) or draw water into the colon (osmotic laxatives). These move stool but do nothing for the underlying motility dysfunction that causes constipation in the first place. Research consistently shows that constipation-dominant gut microbiomes share a specific profile: low Bifidobacterium animalis subsp. lactis and depleted short-chain fatty acid (SCFA) producers like Bifidobacterium longum.

A synbiotic that addresses both — seeding the motility-regulating strains and feeding them with a prebiotic so they colonize — produces lasting relief rather than symptomatic relief. That's the distinction between a synbiotic and a laxative.

What the data shows

Across 23,000+ microbiome profiles, constipation is among the most consistently dysbiosis-linked conditions. The microbial signature is reproducible: low Bifido populations, reduced transit-promoting SCFA output, and often elevated methane producers. A targeted synbiotic addressing these three variables outperforms both generic probiotics and fiber supplements alone.

GoodOnes™ Fundamentals — Powered by Flore Clinical
The Regular One

A targeted synbiotic — one job, one bottle, strain-specific. No filler strains. No generic kitchen-sink formula.

30 days, 5 strains, one job

The Regular One delivers Bifidobacterium animalis subsp. lactis and Bifidobacterium longum at clinically meaningful CFU counts (4B CFU each), on a foundation of three universal Precision core strains, with flaxseed prebiotic to sustain colonization. This is a synbiotic designed for the specific microbial pattern behind constipation — not a generic GI formula.